American Gene™ founder recognized as one of the field’s most dynamic leaders. Jeff Galvin, CEO and founder of American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has… [Read More]
POZ Magazine: HIV Advocates Inspire in “The Cure Chronicles”
Original post on Poz.com By Trent Straube Sexual molestation as a child, an abusive father, the foster care system, violent street gangs, an HIV diagnosis as a teenager. “Anything you can think… [Read More]
Biotech Project Podcast: ‘It’s easy to be excited’ -Jeff Galvin on American Gene’s Unique Gene Therapy Technology
The Biotech Project podcast welcomes CEO and Founder of American Gene Technologies®, Jeff Galvin, onto the show to discuss the past, present, and future of the company’s mission to use… [Read More]
American Gene Technologies® Phase I HIV Gene Therapy Clinical Trial Data Published in Frontiers Journal Shows Success in Safety & Durability
American Gene™ Plans for Phase 2 Trial of AGT103-T American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primary and secondary endpoints… [Read More]
ShareTreck: Raj Natarajan Interviews American Gene™ CEO, Jeff Galvin
Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview to learn how gene therapy works, and what… [Read More]
American Gene Technologies® Chief Medical Officer Honored by UCSF Endowment for HIV Dermatology and LGBTQ Health Research
Dr. Marcus Conant Named in UCSF’s Commitment to Pave Way for Next Generation of HIV Researchers American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, congratulates Dr. Marcus… [Read More]
From Lab to Launch Podcast: Testing a Gene Therapy to Potentially Cure HIV & Fundamentally Change Healthcare with Jeff Galvin
Have a listen. https://www.americangene.com/wp-content/uploads/2022/09/testing-a-gene-therapy-to-cure-hiv-fundamentally-change-healthcare-with-jeff-galvin-of-american-gene-technologies.mp3 From Lab to Launch by Qualio Jeff is the CEO and founder of American Gene Technologies®. He earned his BA degree in Economics from Harvard and… [Read More]
Queerty: Gay men are the “canary in the coal mine” of future pandemics, warns doc seeking HIV cure
Original post on queerty.com By David Hudson The trial of a potential HIV cure is underway. The scientists involved hope for initial results toward the end of the year. One… [Read More]
American Gene Technologies® Welcomes Barry H. Wells, M.D., as Head of Business Development
Dr. Wells’ promotion comes as the company’s HIV clinical trial progresses American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head… [Read More]
Unboxing Biotech Analyst Report: The Foundation Behind a Potential HIV Cure
Download the Report The exact origins of Human Immunodeficiency Virus (HIV) are not precisely known, but researchers theorize that the virus may have originated in chimpanzees,1and then crossed to humans… [Read More]
American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals
Beginning the analytic treatment interruption is a pivotal step to potentially demonstrating a gene therapy cure for HIV. American Gene Technologies, a clinical-stage biotechnology company, has reached a turning point… [Read More]
The Baltimore Sun: Maryland Might Lose Out on a New $1 Billion Federal Medical Research Accelerator
Original post on baltimoresun.com By Giacomo Bologna and Meredith Cohn Baltimore Sun At his State of the Union speech in March, President Joe Biden urged Congress to fund a new federal… [Read More]
